-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $146

Benzinga·08/05/2026 12:21:07
Listen to the news
Guggenheim analyst Vamil Divan maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $145 to $146.